# Minocycline and Celecoxib as Adjunctive Treatments of Bipolar Depression

> **NCT02703363** · PHASE3 · COMPLETED · sponsor: **Pakistan Institute of Living and Learning** · enrollment: 265 (actual)

## Conditions studied

- Depression
- Bipolar Disorder
- Bipolar Depression
- Mood Disorders

## Interventions

- **DRUG:** Minocycline
- **DRUG:** Celecoxib
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02703363
- **Lead sponsor:** Pakistan Institute of Living and Learning
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-08
- **Primary completion:** 2018-12
- **Final completion:** 2018-12
- **Target enrollment:** 265 (ACTUAL)
- **Last updated:** 2019-08-05

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02703363

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02703363, "Minocycline and Celecoxib as Adjunctive Treatments of Bipolar Depression". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02703363. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*